HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew D Griffin Selected Research

Glucose (Dextrose)

1/2022Mesenchymal stromal cell therapy compared to SGLT2-inhibitors and usual care in treating diabetic kidney disease: A cost-effectiveness analysis.
2/2019Effect of Sodium Glucose Co-Transporter-2 Inhibition on the Aldosterone/Renin Ratio in Type 2 Diabetes Mellitus.
2/2007Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies.
6/2005New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthew D Griffin Research Topics

Disease

8Inflammation (Inflammations)
04/2024 - 06/2012
8Diabetic Nephropathies (Diabetic Nephropathy)
03/2024 - 05/2016
7Fibrosis (Cirrhosis)
04/2024 - 08/2003
6Acute Kidney Injury (Acute Renal Failure)
01/2020 - 09/2005
5Chronic Renal Insufficiency
10/2023 - 09/2007
4Chronic Kidney Failure (Chronic Renal Failure)
04/2009 - 07/2005
3Hyperglycemia
04/2024 - 06/2005
3Type 2 Diabetes Mellitus (MODY)
10/2023 - 02/2019
3Autoimmune Diseases (Autoimmune Disease)
01/2022 - 06/2006
3Proteinuria
11/2021 - 09/2006
3Kidney Diseases (Kidney Disease)
01/2021 - 09/2007
3Atrophy
04/2008 - 05/2005
2Body Weight (Weight, Body)
04/2024 - 03/2024
2Autosomal Dominant Polycystic Kidney (ADPKD)
06/2019 - 01/2013
2Ischemia
01/2018 - 08/2005
2Necrosis
12/2016 - 09/2014
2Ureteral Obstruction
12/2014 - 02/2012
2Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
04/2009 - 09/2006
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2006 - 03/2004
1Orthostatic Hypotension (Postural Hypotension)
03/2023
1Heart Failure
03/2023
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2022
1Vasculitis (Vasculitides)
11/2021
1Nephrotic Syndrome (Syndrome, Nephrotic)
11/2021
1Cysts
01/2021
1Sepsis (Septicemia)
01/2021
1Immune System Diseases (Immune Disorders)
01/2020
1Glomerulonephritis
08/2019
1Diverticulum
06/2019
1Polycystic liver disease
06/2019
1Cholangitis
06/2019
1Gallstones (Gallstone)
06/2019
1Hyperaldosteronism (Conn Syndrome)
02/2019
1Hypertension (High Blood Pressure)
01/2019
1Weight Gain
01/2019
1Albuminuria
01/2019
1Crohn Disease (Crohn's Disease)
12/2016
1Rhabdomyolysis
09/2014
1Osteoarthritis
03/2014
1Atherosclerosis
02/2013
1Polycystic Kidney Diseases (Polycystic Kidney Disease)
01/2013
1Arthritis (Polyarthritis)
07/2012
1Reperfusion Injury
06/2012
1Pulmonary Hypertension
11/2008

Drug/Important Bio-Agent (IBA)

5CreatinineIBA
03/2024 - 08/2003
4Glucose (Dextrose)FDA LinkGeneric
01/2022 - 06/2005
3SodiumIBA
03/2023 - 02/2019
3Proteins (Proteins, Gene)FDA Link
11/2021 - 03/2003
3Biomarkers (Surrogate Marker)IBA
11/2021 - 01/2019
3CytokinesIBA
01/2019 - 09/2007
2Messenger RNA (mRNA)IBA
04/2024 - 08/2005
2Blood Glucose (Blood Sugar)IBA
04/2024 - 03/2024
2Tacrolimus (Prograf)FDA LinkGeneric
01/2018 - 04/2008
2Calcitriol Receptors (Calcitriol Receptor)IBA
12/2014 - 06/2006
2DNA (Deoxyribonucleic Acid)IBA
06/2012 - 12/2005
1MicroRNAs (MicroRNA)IBA
04/2024
1ImmunosorbentsIBA
04/2024
1Therapeutic UsesIBA
04/2024
1EnzymesIBA
04/2024
1AlbuminsIBA
03/2024
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2022
1SymportersIBA
01/2022
1(S-dinitrophenyl)-6-mercaptopurine riboside triphosphateIBA
01/2021
1Chemokine CX3CL1IBA
01/2021
1ChemokinesIBA
01/2021
1Complement System Proteins (Complement)IBA
01/2020
1RNA (Ribonucleic Acid)IBA
11/2019
1Interleukin-6 (Interleukin 6)IBA
08/2019
11-dodecylpyridoxal (PLD)IBA
06/2019
1ReninIBA
02/2019
1AldosteroneIBA
02/2019
1Inosine Diphosphate (IDP)IBA
01/2019
1Activins (Activin)IBA
01/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019
1activin AIBA
01/2019
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2018
1Immunoglobulin G (IgG)IBA
01/2018
1Monoclonal AntibodiesIBA
12/2016
1Infliximab (Remicade)FDA Link
12/2016
1Pattern Recognition ReceptorsIBA
02/2016
1paricalcitol (Zemplar)FDA Link
12/2014
1Interleukin-10 (Interleukin 10)IBA
02/2013
1Apolipoproteins E (ApoE)IBA
02/2013
1Conjugated Linoleic AcidsIBA
02/2013
1LectinsIBA
01/2013
1nutlin 3IBA
06/2012
1Interleukin-1 (Interleukin 1)IBA
02/2012
1InterleukinsIBA
02/2012
1Rituximab (Mabthera)FDA Link
04/2009
1N 30IBA
04/2009
1Chemokine ReceptorsIBA
12/2008
1Serum AlbuminIBA
11/2008

Therapy/Procedure

16Therapeutics
03/2024 - 03/2004
9Kidney Transplantation
01/2021 - 03/2004
2Renal Replacement Therapy (Therapies, Renal Replacement)
01/2021 - 01/2019
1Intravenous Administration
04/2024
1Intravenous Injections
03/2024
1Cholecystectomy
06/2019
1Intravenous Infusions
09/2014
1Cell- and Tissue-Based Therapy (Cell Therapy)
12/2010